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Eosinophilic airway inflammation and structural airway changes are present in school age asthmatics. When
these changes occur, and their relationship, are controversial. Some structural airway changes, up-regulation
of collagens 1 and 111, and increased distance between alveolar tethering points, may be antenatal, and inde-
pendent of inflammation. We have established that there is no eosinophilic inflammation or reticular basement
membrane thickening in wheezing infants median age one year; but by age three years, both are present. This
accords with cohort studies, showing that children who become persistent wheezers have a drop in lung func-
tion in the pre-school years. Thereafter, lung function tracks into middle age, so the preschool years represent
window during which an intervention might have long term benefit. Supportive are measurements in blood and
bronchoalveolar lavage fluid, implicating the neutrophil as the key inflammatory cell in early wheeze. Models of
the pathophysiology of asthma include (1) that eosinophilic inflammation is the primary event, and leads to re-
modelling as a secondary event, which itself results in progressive airflow obstruction (the least likely model);
(2) eosinophilic inflammation is the primary event, but remodelling is protective, preventing worsening AHR. It
should be noted that these first two are not mutually exclusive; rbm thickening may be protective, but other
components of remodeling, for example increased ASM, may have adverse effects; (3) eosinophilic inflamma-
tion and airway remodelling are parallel processes, driven by some underlying ‘asthma factor’; and (4) the pri-
mary abnormality is not airway inflammation, but some form of disordered airway repair.
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INTRODUCTION
Airway inflammation and remodelling have been
mainly studied in the context of asthma of all the pae-
diatric airway diseases, and this article will only deal
with this condition. Inflammation and remodelling in
other airway diseases has recently been reviewed
elsewhere.1 The old asthma paradigm was that re-
peated cycles of acute and acute on chronic inflamma-
tion in asthma was an early event, which then leads
eventually to airway remodelling, as a manifestation
of incomplete or disordered repair. This would pre-
dict that remodelling would be a late feature of the
asthmatic process. However, this is incompatible with
much pediatric data, reviewed below. At least two
other paradigms have been considered, which will be
discussed in detail below:
Airway inflammation and airway remodelling are
parallel processes, triggered by the same underlying
problem, but the progression of each is independent
The primary abnormality in asthma is not inflam-
mation, but a primarily a disorder of airway repair,
and that inflammation is secondary to these abnormal
repair processes. This idea has given rise to the con-
cept of the Epithelial-Mesenchymal Trophic Unit
(EMTU, see below).2
Currently, there is insufficient evidence that either
of these paradigms is wholly correct, and indeed fur-
ther paradigms will be discussed in this manuscript.
This review will discuss the pathological evidence
with regard to early remodelling, and place it in the
context of what is known about the physiological
changes in early asthma; the implications for the
treatment of asthma will be briefly discussed.
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DEFINITIONS
Remodelling is term used to describe the structural
changes seen in the airways of patients with respira-
tory disease. These structural alterations involve resi-
dential airway cells and, possibly, bone marrow-
derived, pleotropic cells recruited from the circula-
tion.3 Conventionally, the changes of remodelling are
said to include thickening of the reticular basement
membrane (rbm, the signature feature of established
asthmatic remodelling), goblet cell hyperplasia, in-
creased numbers of submucous glands, increase in
blood vessel number and area, smooth muscle hy-
pertrophy and hyperplasia, and increased airway wall
collagen. However, a paediatrician’s view would be
that global reduction in airway size, and interference
with the tether points of alveoli to airway wall, are just
as much structural changes (see below). Hence re-
modelling has many features, which could appear at
different times, and each might bear a different rela-
tionship to airway inflammation.
Inflammation as used in the title of this article will
be taken to mean chronic eosinophilic inflammation,
as seen in the adult with chronic moderate asthma; it
is well known that early acute viral infection, for ex-
ample with respiratory syncytial virus (RSV), causes
neutrophil dominated acute inflammation, with inter-
leukin (IL)-9 production, as shown in blind BAL stud-
ies.4,5 However, although the evidence is still de-
bated,6,7 most would consider that severe RSV infec-
tion is merely a marker for a previously disordered
airway growth and immune maturation, events lar-
gely pre-natally determined. Hence the acute inflam-
mation induced by RSV clears, and symptoms gradu-
ally resolve, and RSV does not cause chronic airway
inflammation, at least of an eosinophilic type; there is
some animal and human evidence that neurogenic in-
flammation may be important after RSV bronchioli-
tis.8,9 The sequelae of viral infections may be struc-
tural airway wall changes, more particularly if the in-
itial bronchiolitis was caused by particular strains of
adenovirus, leading to a severe obliterative bron-
chiolitis, but this is a different phenomenon to asth-
matic airway remodelling, although the physiological
effects of the two (steroid resistant airway obstruc-
tion) may be similar.
Indeed, what is clear from early on is that the com-
mon viral infections of infancy lead to bouts of recur-
rent, acute, but resolving neutrophilic inflammation,
quite different from the chronic persistent eosino-
philic inflammation seen in later asthma. What is not
at all known is, what is the trigger that leads to this
switch, and how can this be modulated?
WHAT HAVE WE LEARNED FROM STUDIES
IN OLDER CHILDREN?
Ethical constraints mandate that paediatric broncho-
scopy should not be carried out unless it is of direct
benefit to the child concerned.10 This is different to
the situation in adults, where purely research bron-
choscopy is well established. However, the acquisi-
tion of samples for research, during a clinically indi-
cated bronchoscopy, with the consent of the family
and age-appropriate assent of the child, is accept-
able.11 An early study demonstrated that some school
age children with severe asthma, despite steroid ther-
apy, had eosinophilic airway inflammation.12 One of
the first blows to the hypothesis that prolonged in-
flammation causes remodelling came from a study of
rbm thickness in children with severe asthma, and
adults with severe and mild asthma.13 Children aged
6―18 years had abnormally thick rbm compared with
“normal” control children and normal adults. There
was no difference between the paediatric and adult
asthmatic groups, and no relationship between dura-
tion of asthma, any marker of airway inflammation, or
anti-inflammatory therapy. Thus the logical conclu-
sion was that rbm thickening at least is a non-
progressive, and probably early change in the devel-
opment of asthma, and was not driven by airway in-
flammation. Subsequent paediatric studies have
shown that school age children have increased epi-
thelial loss and rbm thickening, airway eosinophilia
and increased bronchial vasculature.14 Airway mu-
cosal eosinophil counts correlated with symptom du-
ration, and inversely with TGFβ-R11 expression,
which was downregulated in the asthmatics, but not
the atopic, non-asthmatics.15 Neutrophil, macro-
phage, mast cell and CD4 positive T lymphocyte
counts, and the expression of TGF-β1 and TGFβ-R1
were the same in all three groups (atopic asthmatics,
atopic non-asthmatics, and normal controls. For the
most part, the asthmatic children were not being
treated with inhaled or oral corticosteroids. Some of
these changes were seen in atopic non-asthma-
tics,14,15 but the relationship of atopy without asthma
to structural airway wall changes is still controversial,
largely because it is difficult to justify the perform-
ance of a bronchoscopy in an atopic child with no air-
way disease. In a slightly different approach, de Blic
et al.16 compared children with severe asthma who
did and did not have persistent symptoms despite
high dose treatment. They found increased mucosal
neutrophil and eosinophil counts in the symptomatic
group, no difference in rbm thickness, and increased
IFN-γ and IFN-γ: IL-4 ratio in the group with few
symptoms. We have recently described airway
smooth muscle (ASM) hypertrophy and hyperplasia
in children with asthma, as well as other inflamma-
tory lung diseases; in the asthmatic group, ASM
changes correlated with bronchodilator reversibil-
ity.17 Taken together, these results show that eosino-
philic inflammation and many features of remodelling
are both present in even early school age children,
and that some features at least of remodelling are
non-progressive.
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Is there any evidence as to the relationship be-
tween inflammation and remodelling in older chil-
dren? Payne et al compared airway histology in chil-
dren with severe asthma who did, and did not, have
persistent airflow limitation (PAL, defined as FEV1 <
80% with FEV1FVC ratio < 0.8, despite high dose
systemic corticosteroids), compared with non-asth-
matic controls.18 Mucosal CD4, but not CD8 positive
T-lymphocytes were inversely correlated with pre-
and post-bronchodilator FEV1. Interestingly, those
children who did not have PAL had a greater rbm
thickness than the PAL asthmatics and controls. One
could hypothesis that CD4 lymphocytes might be the
key drivers both of inflammation and remodelling, as
separate but parallel processes. The role of lympho-
cytic bronchial inflammation finds some support from
an adult study19 in which long term lung function de-
terioration was more rapid in those with high bron-
chial CD8 positive lymphocytic infiltration; CD4 cells
were not reported. It seems likely that T-lymphocytes
modulate remodelling in some way, but more work is
needed.
These observations were taken further in a bron-
choscopic study of children age 5―15 years with mod-
erate and severe asthma who underwent broncho-
scopy.20 Control tissue was from children who had
died in road traffic accidents. The authors stained for
markers of epithelial stress, specifically epidermal
growth factor receptor (EGFR) and the cyclincyclin
dependant kinase inhibitor p21waf, and the epithelial
proliferation marker Ki67. There salient findings in
the asthmatics as compared to normals were as ex-
pected a thickening of the rbm and increased colla-
gen deposition; increased staining for EGFR and
p21waf; and reduced Ki67 expression. EGFR expres-
sion correlated with rbm thickness. By contrast,
there was no correlation between eosinophil numbers
and Ki67 or p21waf. Indeed, there was no increase in
eosinophil numbers in any of the groups. The authors
concluded that the epithelium was stressed or injured
without evidence of inflammation. These data are im-
portant, but not easy to interpret. Clinical details are
scanty, and it is difficult to see whether there may
have been confounding effects of treatment; all the
severe, and one of the moderate asthmatics was re-
ceiving treatment with inhaled corticosteroids. These
authors have proposed from these and other data the
concept of dysfunction of the EMTU being disturbed
in asthma. The EMTU concept2 proposes that the epi-
thelial damage in asthma is a result of disregulated
EFGR-mediated repair. The damaged epithelium
combined with a TH2-mediated environment, leads to
myofibroblast activation, matrix deposition, and me-
diator release, amplifying the airway wall remodel-
ling. The interaction between epithelium and mesen-
chyme is fundamental to normal airway development,
and it is proposed that this becomes dysregulated ex
utero in the asthmatic. This would lead away from in-
flammation being the primary abnormality, and to-
wards asthma being a primary disorder of airway re-
pair and remodelling. The relationship between onset
of symptoms, and airway inflammation and remodel-
ling was studied by Pohunek et al.21 They performed
bronchoscopy in children with chronic respiratory
symptoms, prior to a specific diagnosis having been
made. The group were re-evaluated 22―80 months
later, and those who were subsequently assigned a
diagnosis of asthma were found to have increases in
airway eosinophils and rbm thickening at the previ-
ous bronchoscopy, compared to those who were not
subsequently thought to be asthmatic. As in other
studies, there was no correlation between the two.
They concluded that histological changes were pre-
sent very early in the development of asthma, in a
“pre-morbid” phase. However, some comment needs
to be made. All patients had had symptoms for at
least a year prior to the bronchoscopy (mean nearly 4
years). Only 3 of 27 of the children were less than five
years old. Thus it is arguable that in fact the study
was in patients with fairly well-developed asthma,
many of whom, with retrospect, could have been
given a diagnosis of asthma much earlier, at the time
of, or even before, the initial bronchoscopy. These re-
sults have been challenged by subsequent studies
(below).
WHAT IS THE EVIDENCE FROM EPIDEMI-
OLOGY?
The evidence detailed above suggests that eosino-
philic airway inflammation and structural airway wall
changes are present by the early school years, and
the roots of the problem lie earlier in life. Different
patterns of pre-school wheeze have been described,
with different lung function abnormalities.22,23 There
is not complete agreement in all cohort studies, but in
summary, transient wheezers (defined as wheeze in
the first three years of life, symptom free at age six)
have impaired lung function at birth, and show im-
proved, but persistent airflow obstruction at age six.
Persistent wheezers (wheeze throughout the first six
years of life, many of whom are the future atopic asth-
matics) had normal lung function at birth, but airflow
obstruction age six years. Late onset wheezers (no
wheeze in the first three years of life, but wheeze in
the second three years) have normal lung function to
age six years.22 Thereafter, from age six to sixteen
years, lung function tracks.24 In contrast, the Perth
group found evidence of impaired lung function even
at birth in the future persistent wheezer.23 What does
seem clear, from a series of overlapping cohort stud-
ies,25,26 is that lung function tracks from about 3―5
years of age until nearly 50; in other words, lung func-
tion until late middle age is predetermined in the pre-
school years, and therefore it is at this time that the
roots of inflammation and remodelling should be
sought.
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ANTENATAL REMODELLING
What is clear from epidemiology is that there are at
least some structural changes are determined antena-
tally. Whether this is termed remodelling is a matter
of definition, but it is useful briefly to focus on them,
because their effects are long-lasting (above), and
they may in the future provide an opportunity for fu-
ture therapeutic intervention. Airway branching is
pattern is determined in the first half of pregnancy,
and thereafter, antenatal influences can affect airway
calibre. There are a number of antenatal determi-
nants of airway anatomy. These include genes, of
which the best characterised is ADAM33, which is
important in antenatal lung development,27 in particu-
lar branching morphogenesis, and polymorphisms of
which also affect airway calibre at age 3 and 5 years.28
Interestingly, however, the ADAM33 null mouse has
no pulmonary phenotype at all,29 so there must be
considerable redundancy in the system. The most ob-
vious intrauterine environmental effect is maternal
smoking, which is associated with airflow obstruction
shortly after birth in the fetus. There are important
gene-environment interactions; maternal and fetal
glutathione metabolising enzyme phenotype both in-
teract with environmental smoke; the fetal exposure
to maternal smoke is greater if the mother carries
null polymorphisms, and the consequences are
greater for the null child.30,31
The knowledge of the effects of the mother smok-
ing on the development of the foetal lungs has come
from animal and human work. Pregnant guinea pigs
exposed to tobacco smoke gave birth to pups with a
greater than normal distance between alveolar attach-
ment points, due both to an increase in the outer pe-
rimeter of the airway, and a reduction in the number
of attachments. There were also non-significant
trends for inner and outer airway wall area, and ASM
area to be increased compared with controls.32 Nico-
tine given by subcutaneous infusion to pregnant ba-
boons caused airway remodelling in the pups.33
There was increased airway wall area per mm of epi-
thelium, and upregulation of mRNA for Types 1 and
111 collagen, confirmed by immunostaining, in the
airway and alveolar walls. There were also increases
in elastin mRNA, but if anything, elastin protein was
decreased, not increased; this counter-intuitive result
did not reach statistical significance. The mechanism
is probably via the reaction of nicotine with the α7
nicotinic acetyl choline receptor. These changes were
not reported to be associated with inflammation, es-
tablishing proof of concept that inflammation is not a
pre-requisite for airway remodelling.
The most extensive human studies have come
from autopsy data from Melbourne, Australia.34-36 In
the first study, the lungs of infant victims of sudden
infant death syndrome (SIDS) whose mothers did
and did not smoke in pregnancy were compared.34 Of
course, it could be argued that the best control group
would be trauma victims, because it could be argued
that some changes may have been related to a ge-
netic or other predisposition to SIDS, independent of
maternal smoking. In the first study, inner airway
wall thickness relative to the basement membrane pe-
rimeter was found to be greater in the large airways
of the SIDS infants whose mothers smoked in preg-
nancy. In a subsequent study, the controls were non-
SIDS related deaths, the SIDS victims had increased
ASM, but epithelial and wall thicknesses were similar
in the two groups.35 However, pregnancy smoking
history did not affect airway ASM content. The final
study,36 this time without non-SIDS controls, showed
an increased distance between alveolar attachment
points in those with a history of antenatal smoke ex-
posure, similar to the findings in guinea pigs (above).
They confirmed that there was no difference in air-
way or parenchymal elastin content in either group.
Postnatal smoke exposure had no effect on alveolar
attachment points. The thickness of the inner airway
wall was greater in the ante-natal smoke exposure
group. Taken together, these animal and human data
suggest that antenatal smoke exposure can cause a
form of remodelling characterized by increased types
1 and 111 collagen, increased inner airway wall thick-
ness, and an increased distance between alveolar at-
tachment points. The functional consequences might
be to alter airway wall compliance, a consequence
supported by complex mathematical modeling based
on physiological observations in humans.37
There are other maternal factors known to be asso-
ciated with airflow obstruction in the antenatal pe-
riod, although the pathology in the neonatal airway
has not been characterized, and thus whether they
also cause remodelling is not known. Maternal atopy
has also been associated with impaired lung function
in the newborn, although the precise mechanisms
are not clear.38,39 Other factors include maternal hy-
pertension or pre-eclampsia, which is associated with
an increased risk of transient early wheezing, persis-
tent wheezing and late-onset wheezing. Use of antibi-
otics for urinary tract infections was associated with
transient early wheezing, and antibiotic administra-
tion at delivery was associated with both transient
early wheezing and persistent wheezing.40 Children
who had a mother with diabetes were more likely to
have persistent wheezing.40 Finally, amniocentesis or
chorionic villus sampling was associated with the sub-
sequent development of wheezing.40 Further mecha-
nistic studies are needed in babies with these preg-
nancy histories.
A WINDOW OF OPPORTUNITY? BRON-
CHIAL BIOPSY STUDIES IN YOUNG CHIL-
DREN
Two studies from our group have established the
pathological counterpart of the epidemiological find-
Inflammation & Remodelling in Children
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ings of changes in lung function between birth and
age six years.41,42 In the first,41 infants, median age 12
months were investigated for persistent respiratory
symptoms in Helsinki. As part of the investigations,
bronchoscopy and endobronchial biopsy were per-
formed. The infants were divided into three groups,
(A) those with airflow obstruction, responsive to
acute administration of bronchodilators; (B) a group
with airflow obstruction, non-responsive to bron-
chodilators; and (C) the group with normal lung func-
tion. Group C was the nearest equivalent to normal
controls that could be obtained, given the ethics of
bronchoscopy in young children. There was no differ-
ence in rbm thickness, or any inflammatory cell, in
any group. Nor was there any difference between the
group at highest risk for persistent wheeze (atopic
children in Group A) and the others or any subgroup
thereof. The biopsies all looked entirely normal and
featureless, despite the presence of symptoms of a se-
verity and duration to provoke referral to a specialist
centre. It will be of interest to re-analyse the data
when the infants are age 6 years, and can be repheno-
typed by the Tucson criteria (22 and see above). It
would of course have been of interest to perform fol-
low up biopsies, but this is not ethical.
We also performed a second, cross-sectional study
in a different group of pre-school children, referred to
The Royal Brompton for investigation of really severe
wheeze. They were divided into confirmed wheezers
(using a videoquestionnaire43) and unconfirmed
wheezers, a group in whom parents identified a differ-
ent noise on the questionnaire. Control children were
those being investigated for stridor, other upper air-
way problems, and hemoptysis, who had never
wheezed. The confirmed wheeze group had rbm
thickening, and eosinophilic airway inflammation on
endobronchial biopsy, with a good correlation be-
tween the two. Of course, correlation does not prove
causation, or even association. In a post-hoc analysis,
there was a marked trend for the changes to be more
marked after rather than before the second birthday.
These children are currently being followed up and
rephenotyped at school age, when the data can be re-
analysed by retrospective phenotype. Thus these two
studies suggest that there may be a window between
the onset of symptoms, and two years of age, during
which time the airway pathology of asthma develops
in those who will turn out to have persistent wheeze.
In terms of the nature of the rbm changes, we com-
pared the fibrillary structure using electron micros-
copy, in these infants, and older children and adults
with asthma.44 The fibrillary structure was identical,
implying that the changes seen were due to an in-
crease in the normal content of the RBM, and not a
fundamental change in structure, which would have
implied the laying down of new components beneath
the normal rbm.
SUPPORTIVE EVIDENCE: OTHER STUDIES
IN YOUNG CHILDREN
The concept we propose, namely that there is a win-
dow between the onset of symptoms, and the estab-
lishment of eosinophilic airway inflammation receives
support from other studies of pre-school wheeze. The
initial pattern of inflammation would appear to be in-
termittent and acute neutrophilic, rather than eosino-
philic. In acute preschool presumed viral induced
wheeze, serum soluble L-selectin was increased, and
membrane bound L-selectin (CD61) was reduced, im-
plying neutrophil activation.45 BAL studies have
shown that preschool wheeze is associated with a
neutrophilic cytology, similar to cystic fibrosis, rather
than the typical eosinophilic pattern seen in atopic
asthmatics.46,47 This was confirmed by a non-bron-
choscopic BAL study, which showed that viral associ-
ated wheezers had no eosinophilic airway inflamma-
tion.48 Treatment with oral and inhaled steroids is
very effective in atopic, eosinophilic asthma, but has
minimal if any benefits in pre-school viral associated
wheeze,49-51 again implying a lack of eosinophilic in-
volvement. Finally, in a natural experiment, young
children with autoimmune neutropaenia were match-
ed with a control group with the same number of
atopic first degree relatives; none of the neutropaenic
group developed asthma, significantly different from
the control group.52 Thus eosinophilic involvement is
not early in the evolution of wheeze in the pre-school
child.
IMPLICATIONS FOR TREATMENT
It is when considering treatment that the importance
of the different paradigms is most obvious. If remod-
elling leads to progressive airflow obstruction, then
preventive treatment is appropriate. However, there
is at least some evidence that rbm thickening may be
protective, and intuitively, if it stiffens the airway and
prevents constriction this might protect long term
lung function. We showed that rbm thickening ap-
peared to be associated with better lung function
(18, and see above). However, an adult study53 show-
ed the reverse. A physiological study suggested that
rbm thickening may be protective against BHR.54
Thus the data as to benefit or otherwise for rbm
thickening is unclear. There are even fewer data for
other components of remodelling, although one
study showed a correlation between worse lung func-
tion and greater ASM thickening.55 It is possible that
some components of remodelling are protective,
whereas others are adverse. Therefore caution
should be employed before attempting to modulate
remodelling, and more data are needed.
FUTURE WORK
Ideally, we need techniques by which we can directly
measure the separate components of inflammation
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and airway remodelling non-invasively, reliably and
repeatably. None exist. High resolution CT scanning
(HRCT) in adults has shown that there are good cor-
relations between spirometric indices of airflow ob-
struction, rbm thickening and HRCT measurements
of airway wall thickness.53 In our hands, the use of
qualitative or quantitative measurements of airway
wall thickness on HRCT did not correlate with rbm
thickness.56 De Blic et al have found some weak cor-
relations,57 but the spread of the data is such that it is
difficult to believe they would be of use in individu-
als.58 They also partitioned nitric oxide (NO) produc-
tion into airway wall (JNO) and alveolar (Calv) by
measuring NO production at different flow rates.59
They reported a weak correlation between HRCT
measurements and JNO.57 However, since JNO corre-
lates with FeNO50 (NO measured at an expiratory
flow rate of 50 mlsec,59 and FeNO50 is a marker of
eosinophilic airway wall inflammation, it is more
likely that their results reflect a relationship between
inflammation and airway thickening, rather than air-
way thickening itself. In a separate paper,60 they re-
ported further correlations, Calv with BAL TGF-β and
JNO with rbm thickness and TIMP1: MMP9. How-
ever, the complex interdependence of these factors
makes interpretation difficult, and it is difficult to be-
lieve that partitioning NO production will help moni-
tor airway remodelling. In any case, the technique is
not appropriate to the age group of interest, namely
preschool children (above).
Other possibilities include exhaled breath conden-
sate (EBC), and sputum induction. EBC is non-
invasive, which is attractive, but as yet no useful
biomarkers for remodelling have been identified. It
may seem paradoxical to suggest induced sputum as
a technique in an age group which do not spontane-
ously expectorate sputum, but the technique has
been used even in babies to diagnose tuberculosis,61
so in principle this technique could be used to study
inflammation and remodelling. Urine is a very attrac-
tive source of biomarkers. Desmosine (DES) and
isodesmosine (IDES) are amino acids derived exclu-
sively from cross-linked elastin. Hydroxylysylpyridi-
noline (HP) and lysylpyridinoline (LP) are amino ac-
ids derived exclusively from cross-linked collagen. All
have been measured in urine, but there are no data
correlating them with endobronchial biopsy in chil-
dren. Adult studies suggest that they may be useful
markers of tissue destruction.62-66 They are not spe-
cific to the lung, but in the absence of important sys-
temic disease, an elevation in levels is most likely at-
tributable to some event within the lungs. However,
remodelling is not the same as tissue destruction.
More data are needed to determine if there is a role
for these biomarkers.
In adults, the relationship between allergens, in-
flammation and remodelling has been studied using a
model of acute endobronchial allergen challenge.67
This model has shown myofibroblast differentiation
and airway deposition of matrix components such as
tenascin in response to acute allergen challenge,
which would appear to contradict the concept of re-
modelling being an early and non-progressive phe-
nomenon. However, at least some of the changes re-
gress after the challenge, if a later bronchoscopy is
performed (for example, changes in tenascin were no
longer significantly different over baseline; and it
would have been of interest to repeat the broncho-
scopy a few eeks after the challenge),68 and it is diffi-
cult to determine the relationship between acute en-
dobronchial challenge, and the more physiological,
low dose exposures seen in real life. If each allergen
exposure lead to the cumulative deposition of matrix
components in the airway, then the airway would
surely rapidly become obliterated, which simply does
not happen. Furthermore, ethical constraints pre-
clude the application of these techniques in young
children.
If human studies fail, can animal models help?
There are numerous studies in the very unphysiologi-
cal adult mouse model, in which ‘asthma’ is induced
by convoluted procedures including intraperitoneal
ovalbumen injection. We need to develop animal
models which more closely mimic real life―these
will need to be in neonatal animals, with inhalational
(and in particular, viral) challenges. The adult animal,
with fully developed airways and a mature immune
system, cannot possibly mimic the newborn situation.
More satisfactory animal models will allow us to gen-
erate hypotheses, which will then be tested in pre-
school children. It is quite clear that disease modify-
ing interventions are only likely to work in the pre-
school years. In the human, by school age, the dis-
ease is established, and probably not modifiable.
The really relevant question is, what will be the dis-
ease modifying therapies? Inhaled corticosteroids are
definitely not the answer.49,50,69-71 Could it be that
macrolides, with their ubiquitous effects,72,73 might
modify remodelling,74 and thus the natural history of
asthma, as they have of diffuse panbronchiolitis? That
would be another tremendous benefit of East meet-
ing West!
SUMMARY AND CONCLUSIONS
The whole area of early inflammation and remodel-
ling is still controversial. It is clear that some struc-
tural changes take place antenatally, and these are
likely (but not proven) independant of inflammation.
Biopsy of the airways of the very young infant with
symptoms, the only real way of studying early dis-
ease, reveals no inflammation or remodelling. The ab-
sence of eosinophilic inflammation at least is sup-
ported by studies showing that the neutrophil ap-
pears to be the key effector cell in pre-school wheeze,
and also by the at best weak effects of corticosteroids
in early life. There are at least four possible models
Inflammation & Remodelling in Children
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which could describe the relationship between in-
flammation and remodelling:
Eosinophilic inflammation is the primary event,
and leads to remodelling as a secondary event, which
itself results in progressive airflow obstruction. In
this case, treatment of eosinophilic inflammation
would be expected to be disease modifying. This is
completely against the observation of the failure of in-
haled corticosteroid to be disease modifying, and this
model is in my view the least likely.
Eosinophilic inflammation is the primary event, but
remodelling is protective, preventing worsening
AHR. In this case, the concept of preventing remodel-
ling pharmaceutically is misplaced, and possible we
should even be trying to enhance it. It should be
noted that 1. and 2. are not mutually exclusive; rbm
thickening may be protective, but other components,
for example increased ASM, may have adverse ef-
fects.
Eosinophilic inflammation and airway remodelling
are parallel processes, driven by some underlying
‘asthma factor’, perhaps via a CD4 lymphocytic bron-
chitis.
The primary abnormality is not airway inflamma-
tion at all, but some form of airway remodelling, per-
haps related in some way to the EMTU. In this
model, airway inflammation is a secondary problem,
and treating it will not modify the disease process.
Unravelling these hypotheses, or producing newer
and better ones, will require new strategies. Broncho-
scopic biopsy can only provide tiny and very precious
pieces of tissue, and can never be applied to longitu-
dinal studies. At best, the tissue can be used to con-
firm hypotheses. There is an urgent need for
biomarkers that can be utilised in preschool wheez-
ers. Urine is an obvious possibility; induced sputum
might be used to demonstrate airway cellularity; and
exhaled breath condensate might also have a role.
Animal models have been severely criticised, and it is
difficult to see the physiological relevance to early
disease of an adult mouse model that needs an intrap-
eritoneal allergen injection to make it work. However,
increasingly models requiring merely inhalational
challenge, and models of asthma in the newborn air-
way, are being devised. These are ideal for hypothe-
sis generation. Ultimately, a portfolio of techniques
will be needed to determine how and why the pattern
of intermittent, neutrophilic inflammation, with com-
plete resolution, switches to chronic eosinophilic in-
flammation and structural airway wall changes, and
thus how long term lung health can be modulated in
early life, with preservation of airway function into
adult life.
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